Previous studies have found that PROM2 was up-regulated in a variety of tumors, such as bladder cancer, pancreatic cancer, melanoma.7,10,22 However, the potential role and mechanism of PROM2 in NSCLC remains unclear. This evidence concerns the gene PROM2 and pancreatic neoplasm.